Entity
  • Access Accelerated

    Created in 2017
  • BETA

    To investigate (B)
    Some signals may appear as inconsistent with a regular activity
  • Social networks

    6,030 1,871
  • Activities

  • Entity types

  • Location

    Chem. des Mines 9/195, 1202 Genève, Switzerland

    Genève

    Switzerland

  • Employees

    Scale: 2-10

    Estimated: 3

  • Engaged corporates

    20
    5 18
  • Added in Motherbase

    2 years, 4 months ago
Description
  • Value proposition

    Working towards a future where no one dies prematurely from NCDs and all have access to prevention, treatment and care.

    Access Accelerated is an initiative that brings together leading biopharmaceutical and life science companies committed to tackling the growing burden of non-communicable diseases (NCDs) in low- and middle-income countries. Together with partners from across the global biopharmaceutical sector, multilateral organizations and non-governmental organizations, Access Accelerated works toward a future where no one dies prematurely from treatable, preventable diseases.

    Launched in 2017, the initiative works to identify and break down barriers to NCD prevention, treatment and care by uniting the efforts of the biopharmaceutical industry and applying the member company’s global reach and local expertise to address the NCD challenge. We believe in and work to support inclusive local and country-led engagement and ownership.

    Addressing the scale and complexity of the NCD challenge requires deeper and stronger collaboration, across all sectors. Through listening, learning and acting together, we believe we can co-create scalable and sustainable solutions to improve people’s health.

    Access Accelerated supports the UN Sustainable Development Goals to ensure healthy lives and promote well-being for all at all ages (SDG 3) and effective global partnerships for sustainable development (SDG 17). Our work is in support of achieving the specific NCD target to reduce premature deaths related to NCDs by one-third by 2030 (SDG 3.4)

    Access Accelerated recognizes that only by putting the needs of people living with NCDs first and acting in collaboration with partners can the global community make measurable and sustainable progress against NCDs in developing countries.

    For more information, please visit www.AccessAccelerated.org

    Noncommunicable Diseases, Health Financing, Universal Health Coverage, and Access

  • Home - Access Accelerated

    Access Accelerated unites biopharmaceutical and life science companies to collectively respond to the rising NCD burden in LMICs.

  • https://accessaccelerated.org/
Corporate interactions BETA
Corporate TypeTweets Articles
中外製薬 / Chugai Pharmaceutical Co., Ltd. 中外製薬 / Chugai Pharmaceutical Co., Ltd.
Pharmaceutical
Other

15 Jun 2024


Medtronic
Medtronic
Pharmaceutical, Medical Equipment Manufacturing
Medtronic
Pharmaceutical, Medical Equipment Manufacturing
Other

15 Jun 2024


Deloitte
Deloitte
Consulting, audit, Business Consulting and Services
Deloitte
Consulting, audit, Business Consulting and Services
Other

15 Jun 2024


Chatham House
Chatham House
Think Tanks
Chatham House
Think Tanks
Other

15 Mar 2023


MSD
MSD
Pharmaceutical, Pharmaceutical Manufacturing
MSD
Pharmaceutical, Pharmaceutical Manufacturing
Other

2 Jul 2020


Amgen
Amgen
Biotechnology, Biotechnology Research
Amgen
Biotechnology, Biotechnology Research
Other

19 Nov 2020


AstraZeneca
AstraZeneca
Pharmaceutical, Pharmaceutical Manufacturing
AstraZeneca
Pharmaceutical, Pharmaceutical Manufacturing
Other

8 Apr 2021


Novo Nordisk
Novo Nordisk
Pharmaceutical, Pharmaceutical Manufacturing
Novo Nordisk
Pharmaceutical, Pharmaceutical Manufacturing
Other

27 Jun 2024


Bayer
Bayer
Pharmaceutical, Chemistry, Chemical Manufacturing
Bayer
Pharmaceutical, Chemistry, Chemical Manufacturing
Other

13 Jan 2021


The World Bank
The World Bank
International development, International Trade and Development
The World Bank
International development, International Trade and Development
Other

18 May 2023

18 Sep 2024



Similar entities
Loading...
Loading...
Social network dynamics